Page last updated: 2024-09-04

ezetimibe and Pancreatic Neoplasms

ezetimibe has been researched along with Pancreatic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armenoult, L; Ayadi, M; Barraud-Blanc, M; Bian, B; Bigonnet, M; Blum, Y; Boher, JM; Bories, E; Calvo, E; de Reyniès, A; Delpero, JR; Duconseil, P; Dusetti, N; Elarouci, N; Ewald, J; Garcia, S; Garnier, J; Gasmi, M; Gayet, O; Gilabert, M; Giovannini, M; Goncalves, A; Grandval, P; Guillaumond, F; Iovanna, J; Lomberk, G; Loncle, C; Maignan, A; Marisa, L; Moutardier, V; Nicolle, R; Norguet, E; Ouaissi, M; Poizat, F; Raoul, JL; Roques, J; Rubis, M; Secq, V; Turrini, O; Urrutia, R; Vasseur, S1

Other Studies

1 other study(ies) available for ezetimibe and Pancreatic Neoplasms

ArticleYear
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.
    Cell reports, 2017, Nov-28, Volume: 21, Issue:9

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Transformation, Neoplastic; Datasets as Topic; Ezetimibe; Humans; Male; Mice; Pancreatic Neoplasms; Spheroids, Cellular; Xenograft Model Antitumor Assays

2017